Who is sponsoring NCT05317897?

NCT05317897 is sponsored by Kasr El Aini Hospital.

What drugs are being tested in NCT05317897?

Interventions in NCT05317897: Lung ultrasound examination.

What condition does NCT05317897 study?

NCT05317897 studies Exta Vascular Lung Water.

Is NCT05317897 still recruiting?

NCT05317897 is currently completed. Last updated 17 January 2025.

Last reviewed 2025-01-17 · How we verify

NCT05317897

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Utility of Lung Ultrasonography As a Predictor of Fast Track Extubation

Completed Last updated 17 January 2025

What this trial tests

trial testing Lung ultrasound examination in Exta Vascular Lung Water in 45 participants. Completed in 1 August 2022.

Timeline

20 September 2018

Primary endpoint
1 June 2022

1 August 2022

Quick facts

Lead sponsor	Kasr El Aini Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	45
Start date	20 September 2018
Primary completion	1 June 2022
Estimated completion	1 August 2022
Sites	2 locations across Egypt

Drugs / interventions tested

Lung ultrasound examination

Conditions studied

Exta Vascular Lung Water — all drugs for Exta Vascular Lung Water →

Sponsor

Kasr El Aini Hospital

Who can join

Adults 6 Months to 7, any sex, with Exta Vascular Lung Water. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fast-tracking in cardiac surgery refers to early extubation to reduce costs and perioperative morbidity. The use of lung ultrasound is recently accepted as a tool in the assessment of several lung conditions. The aim of this study was to assess the use of lung ultrasound score as a quantitative method to assist in the decision of early extubation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lung ultrasound examination

Trials testing the same drug.

NCT02244723 — Diagnostic Value of Lung Ultrasound for Ventilator-Associated Pneumonia · completed

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

NCT07438652 — Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT · NA · recruiting
NCT07488039 — Labroplasty in Cases of Anterior Shoulder Instability With Subcritical Glenoid Bone Loss · NA · recruiting
NCT07274280 — Comparative Evaluation of Ambu AuraGain, LarySeal Pro and I-gel in Pediatric Airway Management for Day-Case Surgery Unde · NA · not yet recruiting
NCT07348146 — Hand-Sewn vs. Stapled Anastomosis in SADI-S: Early Postoperative Complications. · NA · enrolling by invitation
NCT07077265 — Comparing Two Different Norepinephrine Infusion Rates for Prophylaxis Against Spinal-induced Hypotension in Elderly · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05317897 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kasr El Aini Hospital
Last refreshed: 17 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05317897.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing